On 12/30/20, Xenon Pharmaceuticals Inc (NASDAQ: XENE) stock enjoyed a major increase of 11.3%, closing at $16.04. Moreover, trading volume in this advance was above average at 139% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 12.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, XENE is expected to be a major Value Eraser.
XENE has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. XENE has a very low Power Rating of 11 and a very low Appreciation Score of 6, with the Lowest Value Trend Rating the result.
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.